Investment
Features
FeesSafety
Academy
More
Pluang+

Compare uniQure N.V. Ordinary Shares (QURE) vs US Bancorp (USB) Price & Performance

uniQure N.V. Ordinary SharesTrade
US BancorpTrade

Price performance (Past 24H)

Key statistics

uniQure N.V. Ordinary Shares vs US Bancorp — how do they compare? uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B), while US Bancorp trades at $56.26 (market cap $88.64B). The key difference: US Bancorp is far larger — about 59.9× uniQure N.V. Ordinary Shares's market cap, and US Bancorp pays a 3.8% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and US Bancorp for 98 Days on average.

QUREUSB
Market Cap
$1.48B$88.64B
Volume
2,488,7808,200,583
Sector
HealthFinancials
52-Week High
$70.59$65.42
52-Week Low
$9.03$45.47
Typical Hold Time
0 Days98 Days
Enterprise Value
$728.62M$118.14B
Dividend Yield
—3.8%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

US Bancorp

U.S. Bancorp (USB) trades at $56.89, down 0.92% with bearish technical signals but strong fundamentals including consistent earnings beats and a 27.61% net margin. The stock shows a P/E of 11.36 and ROE of 13.53%, with analyst consensus at Buy (51%) and a $69.94 price target. Recent news highlights dividend increases and strong Q3 expectations for net interest income and fee revenues.

Outlook remains positive based on valuation and earnings momentum, though risks include regulatory changes and interest rate sensitivity. The 3.8% dividend hike to $0.54 signals management confidence, but investors should monitor net cash flow trends and competitive pressures in regional banking.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

QURE
100% Buy0% Sell
Avg holding period · 0 Days
USB

No sentiment data available yet.

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →

About US Bancorp

As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.

Read more on USB →